Potentially High Number of Ineffective Drugs with the Standard Shorter Course Regimen for Multidrug-Resistant Tuberculosis Treatment in Haiti-Reference-Cited by-同舟云学术

Potentially High Number of Ineffective Drugs with the Standard Shorter Course Regimen for Multidrug-Resistant Tuberculosis Treatment in Haiti

Published:2019-02-06 Issue:2 Volume:100 Page:392-398
ISSN:0002-9637
Container-title:The American Journal of Tropical Medicine and Hygiene
language:en
Short-container-title:

Author:

Walsh Kathleen F.¹,Souroutzidis Ariadne²,Vilbrun Stalz Charles³,Peeples Miranda²,Joissaint Guy³,Delva Sobieskye³,Widmann Pamphile³,Royal Gertrude³,Pry Jake⁴⁵,Bang Heejung⁴,Pape Jean W.³,Koenig Serena P.⁶

Affiliation:

1. Center for Global Health, Weill Cornell Medicine, New York, New York;

2. Analysis Group, Boston, Massachusetts;

3. The Haitian Group for the Study of Kaposi’s Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti;

4. Centre for Infectious Diseases Research (CIDRZ), Lusaka, Zambia;

5. Division of Biostatistics, Department of Public Health Sciences, University of California, Davis, California;

6. Division of Global Health Equity, Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts

Publisher

American Society of Tropical Medicine and Hygiene

Subject

Virology,Infectious Diseases,Parasitology

Reference45 articles.

1. World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update;Falzon;Eur Respir J,2017

2. Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis;Van Deun;Am J Respir Crit Care Med,2010

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful outcomes for patients with drug-resistant tuberculosis despite civil unrest and COVID-19 in Haiti;PLOS Global Public Health;2023-09-12

2. Who Knew? Injectable TB Drugs Are Not Equal, Despite Drug Susceptibility Testing;Clinical Infectious Diseases;2021-08-18

3. Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis;European Respiratory Journal;2019-12-20

4. Tuberculosis: Current Status, Diagnosis, Treatment and Development of Novel Vaccines;Current Pharmaceutical Biotechnology;2019-07-09

5. What’s Next for the Standard Short-Course Regimen for Treatment of Multidrug-Resistant Tuberculosis;The American Journal of Tropical Medicine and Hygiene;2019-02-06